U.S. Wireless Telecom Stock News

NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Phase 2 Wins Reshape Growth Story In Oncology And Immunology

Pfizer (NYSE:PFE) reported positive randomized Phase 2 results for atirmociclib, its next generation CDK4 inhibitor, in advanced or metastatic breast cancer. The company also reported positive Phase 2 data for tilrekimig, a trispecific antibody, in moderate to severe atopic dermatitis. These readouts highlight progress in Pfizer’s late stage pipeline across oncology and immunology at a key point in its corporate transition. For investors watching NYSE:PFE, these back to back data readouts...
NYSE:DOW
NYSE:DOWChemicals

Is Rising Analyst Optimism Reframing Dow’s (DOW) Supply Chain Role in North American Chemicals?

Dow Inc. recently took part in a fireside chat at the 2026 J.P. Morgan Industrials Conference in Washington, D.C., offering investors a webcast, replay, and transcript of management’s latest commentary. This appearance comes as multiple research firms have upgraded their views on Dow, highlighting potential benefits from geopolitical supply chain shifts for North American chemical producers. With that backdrop, we’ll now examine how rising analyst confidence tied to expected supply chain...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Are Fifth Third (FITB) Dividends And App Upgrades Reframing Its Tech‑Efficiency Investment Story?

Fifth Third Bancorp has recently declared cash dividends on its common stock and multiple preferred series, while rolling out new in‑app money‑management tools and confirming leadership appointments tied to its Comerica acquisition. Together, these moves highlight the bank’s emphasis on shareholder payouts, digital engagement and expansion into key Western and Southwestern markets. Next, we’ll examine how Fifth Third’s expanded mobile budgeting features may influence its existing investment...
NYSE:TGLS
NYSE:TGLSBuilding

Tecnoglass (TGLS) Valuation Check After Recent Share Price Pullback And Mixed Market Signals

Recent share performance and business snapshot Tecnoglass (TGLS) has drawn fresh attention after a mixed stretch in its share performance, with gains over the past week but negative returns over the past month and past 3 months. For context, Tecnoglass operates an architectural glass and windows business with revenue of US$983.61m and net income of US$159.57m, primarily serving commercial and residential construction markets across the United States, Colombia, Panama, and other regions. See...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Ethics Recognition Adds New Dimension To Lam Research AI Investment Story

Lam Research has been named one of the 2026 World's Most Ethical Companies by Ethisphere. This is the company's fourth consecutive inclusion on the list. Lam is the only wafer fabrication equipment provider to receive this recognition in 2026. For investors tracking Lam Research, ticker NasdaqGS:LRCX, this ethics recognition comes with the stock at a share price of $226.47. The company has seen a 5.2% return over the past week and a 22.4% return year to date. The 1 year and 3 year returns...
NYSE:GE
NYSE:GEAerospace & Defense

General Electric (GE) Is Down 7.5% After AI-Driven Defense, Manufacturing Expansion News Is Announced – Has The Bull Case Changed?

In early 2026, GE Aerospace and Palantir expanded their multi-year partnership to deploy agentic AI across U.S. Air Force readiness and GE’s production system, alongside GE Aerospace committing over US$1.00 billion in fresh U.S. manufacturing and supplier investments and plans to hire 5,000 additional workers this year. This combination of AI-enabled maintenance, supply chain automation, and large-scale domestic capacity spending highlights how GE Aerospace is tying software, manufacturing,...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Assessing Ulta Beauty (ULTA) Valuation After The Recent Share Price Pullback

Why Ulta Beauty Stock Is On Investors’ Radar Ulta Beauty (ULTA) has drawn attention after a recent share price pullback, with the stock showing a 19% decline over the past week, 23% over the past month, and 11% over the past 3 months. See our latest analysis for Ulta Beauty. The recent share price pullback, including a 23.5% 30 day share price return and 15.6% year to date share price return, contrasts with Ulta Beauty’s 52.1% one year total shareholder return. This suggests sentiment has...
NYSE:ARE
NYSE:AREHealth Care REITs

Reassessing Alexandria Real Estate Equities (ARE) After A 46% One-Year Share Price Slump

If you are wondering whether Alexandria Real Estate Equities is attractively priced at its recent levels, you are not alone. This article focuses squarely on what the current share price might imply about value. The stock last closed at US$49.40, with a 3.2% decline over 7 days, a 5.9% decline over 30 days, a 0.9% gain year to date, and a 46.6% decline over the past year. Recent coverage has focused on Alexandria Real Estate Equities because investors are reassessing listed real estate and...
NYSE:FLO
NYSE:FLOFood

Will a Large Non‑Cash Impairment and Dave’s Killer Bread Momentum Change Flowers Foods’ (FLO) Narrative

In the past quarter, Flowers Foods, Inc. recorded a large non-cash impairment charge on intangible assets, prompting investors to reassess its near-term outlook and risk profile. Despite this accounting setback, the company’s Dave’s Killer Bread brand continues to gain share in the organic bread category, highlighting the strength of its premium, health-focused portfolio. We’ll now examine how the sizable non-cash impairment, alongside resilience in Dave’s Killer Bread, affects Flowers...
NYSE:TOL
NYSE:TOLConsumer Durables

Should Toll Brothers’ Expanding Luxury Communities and Rising Dividend Require Action From Toll (TOL) Investors?

In recent weeks Toll Brothers has rolled out or opened multiple luxury home communities and new designs across regions including Washington, California, Texas, Florida, Pennsylvania, Georgia, Nevada, Colorado, North Carolina, Utah, and Massachusetts, while also approving a quarterly US$0.26 dividend per share, its sixth consecutive annual increase. This combination of broad-based product expansion into higher-priced, amenity-rich communities and a steady dividend lift underscores the...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

A Look At Blackbaud (BLKB) Valuation As Development Agent AI Tool Reaches General Availability

Blackbaud (BLKB) just rolled out its Development Agent to Raiser’s Edge NXT customers in the U.S., introducing an AI-powered teammate that can autonomously manage donor outreach under human oversight. See our latest analysis for Blackbaud. Despite rolling out the Development Agent and broadening its AI toolkit, Blackbaud’s 30 day share price return of 10.47% and year to date share price return of 26.18% decline sit alongside a 1 year total shareholder return of 31.23% decline. This points to...
NYSE:JPM
NYSE:JPMBanks

Is It Too Late To Consider JPMorgan Chase (JPM) After Its Strong Multi Year Rally?

For investors wondering whether JPMorgan Chase at around US$286.89 is still offering value or if most of the opportunity is already priced in, this article explores what the current share price might indicate. The stock is roughly flat over the past week with a 0.6% decline, while the 30-day and year-to-date returns of 5.2% and 11.9% declines contrast with a 24.6% gain over 1 year and 135.9% over 3 years. Recent coverage has focused on JPMorgan Chase as a bellwether for large US banks, with...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Is It Too Early Or Too Late To Consider Viking Therapeutics (VKTX) At US$35.53?

If you are wondering whether Viking Therapeutics at US$35.53 is still attractively priced or already reflecting high expectations, the next sections will walk through what the numbers suggest about its current valuation. The stock has posted returns of 2.5% over the last 7 days, 22.5% over the last 30 days, 0.3% year to date and 20.6% over the last year. This naturally raises questions about how much future upside or risk is now embedded in the price. Recent share price moves have been...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Malaysian Probe Puts Arm Holdings Government Contract Governance Under Spotlight

Malaysia's anti graft agency has opened a corruption and fraud probe into a major chip design agreement between Arm Holdings (NasdaqGS:ARM) and the Malaysian government. The investigation focuses on a 10 year contract involving substantial payments to Arm in exchange for chip design plans for local manufacturers. Several former ministers and officials in Malaysia have been questioned as part of the inquiry, which brings regulatory and reputational scrutiny to the deal. For you as an...
NasdaqCM:NN
NasdaqCM:NNSoftware

A Look At NextNav (NN) Valuation After Recent Share Price Momentum

What recent performance tells you about NextNav stock NextNav (NN) has attracted fresh attention after recent price moves. The stock closed at US$16.87 and has shown positive returns over the past week, month, and past 3 months, as well as over the past year. See our latest analysis for NextNav. The share price momentum over the past week and month sits on top of a much stronger total shareholder return over one and three years. This suggests that sentiment around NextNav’s growth potential...
NYSEAM:BMNR
NYSEAM:BMNRSoftware

Bitmine Immersion Ties OpenAI Exposure To Growing Ethereum Staking Theme

Bitmine Immersion Technologies (NYSEAM:BMNR) has secured indirect exposure to OpenAI through an $80 million investment in Eightco Holdings. The company reports rapid growth in its Ethereum treasury, including nearly 61,000 additional ETH in a single week. Staking income from its expanded Ethereum holdings is becoming a larger source of recurring crypto-related revenue. Bitmine Immersion Technologies operates at the intersection of high performance computing and digital assets, and these...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Valuation Check As Revenue Growth Meets Ongoing Net Losses In Latest Results

Legend Biotech (LEGN) shares are in focus after the company reported fourth quarter and full year 2025 results, with higher revenue figures alongside net losses that may shape how you think about the stock. See our latest analysis for Legend Biotech. Legend Biotech’s recent results come after a tough stretch for shareholders, with a 1 year total shareholder return decline of 51.03% and a 3 year total shareholder return decline of 58.75%, while the 30 day share price return of 5.52% hints at...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Will Teva’s (TEVA) Olanzapine LAI Milestone and Legal Win Change Its Innovation-Led Narrative?

Teva Pharmaceutical Industries has recently advanced its “Pivot to Growth” strategy, with its innovative medicines portfolio surpassing US$1.00 billion in combined quarterly revenue, FDA acceptance of an olanzapine LAI filing for schizophrenia, and a favorable US appeals court ruling in a patent dispute with Corcept Therapeutics. These regulatory and legal milestones highlight Teva’s shift away from relying solely on traditional generics toward a broader, higher-margin biopharmaceutical...
NYSE:TPR
NYSE:TPRLuxury

How Record FQ2 Results and US$1.50 Billion Payout Plan Will Impact Tapestry (TPR) Investors

In February 2026, Tapestry reported record-breaking FQ2 2026 results, with total revenue up 14% and Coach sales rising 25%, while boosting planned FY2026 shareholder returns to US$1.50 billion through dividends and buybacks. The company also raised its full-year outlook across all key metrics, highlighting management’s confidence in Coach’s momentum and the group’s ability to sustain high margins amid global challenges. We’ll now examine how Tapestry’s upgraded outlook and increased...
NYSE:ICE
NYSE:ICECapital Markets

ICE’s New AI Mortgage Tools And Private Credit Push Might Change The Case For Investing In ICE

In recent days, Intercontinental Exchange, Inc. has launched AI-powered voice and chat agents for its mortgage servicing platform and rolled out ICE Private Credit Intelligence, a data infrastructure service for private credit markets backed by Apollo as an anchor partner. Together, these moves highlight ICE’s push to embed AI across mortgage workflows while extending its data and analytics footprint into the fast-growing private credit space. We’ll now examine how ICE’s AI-enabled mortgage...
NYSE:BCC
NYSE:BCCTrade Distributors

A Look At Boise Cascade (BCC) Valuation After Earnings Beat And Capacity Expansion Plans

What the latest quarterly beat means for Boise Cascade (BCC) Boise Cascade (BCC) recently reported quarterly earnings per share and revenue ahead of analyst estimates, even as seasonal softness and broader market headwinds weighed on the building materials space. The company is also highlighting anticipated growth in its building materials distribution business, recent facility expansions such as the Thorsby i-line project, and steadier engineered wood products pricing as key elements of its...
NYSE:TT
NYSE:TTBuilding

A Look At Trane Technologies (TT) Valuation After New AI Data Center Cooling Advances

Trane Technologies (TT) recently announced upgraded thermal management systems for gigawatt scale AI factories, including two new Continuum Rubin DSX reference designs that integrate with NVIDIA’s Omniverse DSX Blueprint for AI data centers. See our latest analysis for Trane Technologies. Despite the latest product news around AI data centers, recent trading has been mixed, with a 1 day share price return of 0.92% and a 30 day share price return showing an 8.58% decline. However, the 1 year...
NYSE:KO
NYSE:KOBeverage

Will Coca-Cola’s 2026 Governance Battles Reframe KO’s Long-Term Sustainability and Brand Risk Narrative?

The Coca-Cola Company recently outlined a busy 2026 annual meeting agenda, including the upcoming retirement of long-serving director Maria Elena Lagomasino and several shareholder proposals on sustainability, packaging, ingredients, and diversity that the board has advised investors to vote against. These governance and shareholder-activism developments come alongside leadership transition plans and renewed marketing partnerships, highlighting how Coca-Cola is being pushed on environmental,...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Will Qualcomm’s (QCOM) Bigger Dividend and US$20 Billion Buyback Change Its Capital Allocation Narrative?

Earlier this week, Qualcomm’s board approved an increase in its quarterly cash dividend from US$0.89 to US$0.92 per share, lifting the annual payout to US$3.68, and authorized a new US$20.00 billion share repurchase program with no expiration date. Together, the richer dividend and very large buyback underscore management’s emphasis on returning cash to shareholders while the company pursues diversification beyond its core smartphone chip business. We’ll now examine how Qualcomm’s very large...